Methemoglobinemia from topically applied anesthetic spray.
Topically applied anesthetic spray is commonly used as part of premedication for general anesthesia and for endoscopic procedures; it is rarely associated with side effects. In this report, we describe two cases of toxic methemoglobinemia that resulted from topically applied anesthetic spray used before endoscopy. In both cases, standard doses were used; however, methemoglobin levels of 45% and 38% developed within 1 hour of the procedure. Both patients had normal levels of erythrocyte methemoglobin reductase, an indication that this rare but potentially fatal side effect can occur in persons who have no predisposing factors. Because toxic methemoglobinemia is easily treated, our report emphasizes the need to recognize this problem when topically applied anesthetic sprays are used.
Dinneen
S F
SF
Division of Endocrinology/Metabolism, Mayo Clinic Rochester, Minnesota 55905.
Mohr
D N
DN
Fairbanks
V F
VF
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects*; D001566:Benzocaine / Q000009:adverse effects; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced*; D008875:Middle Aged
D000779:Anesthetics, Local; D008012:Lidocaine; D001566:Benzocaine